Salmeterol xinafoate with controlled particle size

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5795594
SERIAL NO

08564278

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to particulate products which may be prepared by methods and apparatus using supercritical fluids. More particularly, the invention relates to pharmaceutical products, in particular easily handled and easily fluidized crystalline forms of salmeterol xinafoate, with controlled particle size and shape.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXO GROUP LIMITEDBERKELEY AVENUE GREENFORD MIDDLESEX UB6 0NN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hanna, Mazen Leeds, GB 34 1117
York, Peter Ilkley, GB3 41 735

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation